Interleukin(IL)-4 and IL-4 receptors in regulation of type 2 immune responses

Bidragets beskrivning

Immune response protects us against invading pathogens; viruses, bacteria, parasites and yeasts. Inappropriately activated immune response can result in autoimmune reaction or allergic reaction. Humoral mediators, cytokines, are critical regulators of various immune responses. This study clarifies, how cytokines especially Interleukin(IL)-4 regulates allergic inflammation. By understanding how IL-4 and its cell surface receptors function, its' therapeutical utilization, for example in autoimmune diseases to redirect immune response to less inflammatory direction may become possible. In this study, we utilize genetically modified knockout and transgenic mice (some of which are unpublished), clinical samples and cell culture models. The study is collaborative project between, TaY, TAYS, Fimlab Inc and NIH (USA) and is based on my previous research (Junttila I et al., J. Exp Med., 2008, Junttila I et al. Nat Chem Biol., 2012, Junttila I et al. J Allergy Clin Immunol., 2013).
Visa mer

Startår

2017

Slutår

2022

Beviljade finansiering

Ilkka Junttila Orcid -palvelun logo
100 788 €

Andra beslut

314204
Akademiforskarens forskningskostnader(2017)
64 800 €
335742
Akademiforskarens forskningskostnader(2020)
200 845 €
326380
Akademiforskarens forskningskostnader(2019)
260 287 €
326379
Akademiforskare(2019)
333 696 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Övriga uppgifter

Finansieringsbeslutets nummer

308048

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet

Identifierade teman

molecular biology, biochemistry, biomedicine